We are live on ! Find out more
CTOR

Citius Oncology
CTOR

15 hedge funds and large institutions have $34.3M invested in Citius Oncology in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
+15
Holders Change %
–
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$5.07M
2
PAMP
Polar Asset Management Partners
Ontario, Canada
+$4.06M
3
GCL
Glazer Capital LLC
New York
+$3.92M
4
WAM
Weiss Asset Management
Massachusetts
+$3.55M
5
MSU
Mizuho Securities USA
New York
+$3.07M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Hudson Bay Capital Management
1
Hudson Bay Capital Management
Connecticut
$5.08M +$5.07M +500,000 New
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$4.06M +$4.06M +400,000 New
GCL
3
Glazer Capital LLC
New York
$3.93M +$3.92M +386,672 New
WAM
4
Weiss Asset Management
Massachusetts
$3.56M +$3.55M +350,000 New
WCMNY
5
Westchester Capital Management (New York)
New York
$3.05M +$3.04M +300,000 New
MSU
6
Mizuho Securities USA
New York
$3.04M +$3.07M +302,749 New
KIM
7
Karpus Investment Management
New York
$2.68M +$2.67M +263,475 New
CH
8
CVI Holdings
Delaware
$1.92M +$1.91M +188,500 New
MP
9
Mangrove Partners
Connecticut
$1.52M +$1.52M +150,000 New
Two Sigma Investments
10
Two Sigma Investments
New York
$1.52M +$1.52M +150,000 New
OCM
11
Oaktree Capital Management
California
$1.37M +$1.37M +135,000 New
AA
12
AQR Arbitrage
Connecticut
$1.27M +$1.27M +125,000 New
TAM
13
Terrapin Asset Management
Florida
$762K +$760K +75,000 New
SCM
14
Shaolin Capital Management
Florida
$508K +$507K +50,000 New
UBS Group
15
UBS Group
Switzerland
$4.06K +$4.05K +400 New

CTOR Hedge Fund Activity: Q4 2022 in Review

15 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Citius Oncology (CTOR) for Q4 2022, worth a combined $34.3M.

Buyers outnumbered sellers: 15 funds opened new CTOR positions and 0 closed out — a net gain of 15 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $5.07M.

  • 15 institutional investors held Citius Oncology (CTOR) as of Q4 2022, up from 0 in Q3 2022.
  • Funds reported $34.3M of Citius Oncology stock for Q4 2022.
  • 15 funds opened new Citius Oncology positions in Q4 2022 and 0 closed out, a net change of +15 holders.
  • The largest Citius Oncology buyer in Q4 2022 was Hudson Bay Capital Management, an estimated $5.07M added.

Based on aggregated 13F filings for Q4 2022.